Company: HURA
Filing Date: 2025-06-06
Form Type: 425
Source: 0001193125-25-137145
Chunk: 69

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-06-06
Form: 425
Chunk 69
---
 a group, and the Company will not assert any such claim with respect to such obligations or the transactions contemplated by this
Agreement. The Company acknowledges and each Investor confirms that it has independently participated in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors. Each Investor shall be entitled to
independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such purpose.

23

8.11 . The titles, subtitles and headings in this Agreement are for
convenience of reference and shall not form part of, or affect the interpretation of, this Agreement.

8.12 . This
Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party; provided that
a facsimile or pdf signature including any electronic signatures complying with the U.S. federal ESIGN Act of 2000, e.g., shall be considered due execution and shall be binding upon the signatory thereto with the same force
and effect as if the signature were an original, not a facsimile or pdf (or other electronic reproduction of a) signature.

8.13
.

(a) Each Investor acknowledges that each of the Placement Agents is acting as a
placement agent on a “best efforts” basis for the Securities and Warrant Shares being offered hereby and will be compensated by the Company for acting in such capacity. Each Investor represents that such Investor was contacted regarding
the sale of the Securities by a Placement Agent or the Company (or an authorized agent or representative thereof) with whom the Investor entered into a verbal or written confidentiality agreement.

(b) Each Investor represents that it is making this investment based on the results of its own due diligence investigation of the Company and
has not relied on any information or advice furnished by or on behalf of the Placement Agents in connection with the transactions contemplated hereby. Each Investor acknowledges that the Placement Agents have not made, and will not make, any
representations and warranties with respect to the Company or the transactions contemplated hereby, and the Investor will not rely on any statements made by the Placement Agents, orally or in writing, to the contrary.

8.14 . This Agreement and the other Transaction Agreements (including all schedules and exhibits hereto and
thereto), together with any side letter agreements with